The Max Foundation (Max) has announced that three patients have started treatment for HER2 negative/HR positive advanced breast cancer (ABC) including CDK4/6 inhibitor therapy in Mozambique through its Max Access Solutions programme.
Trending
- Abuja crash claims 4 lives
- Super Eagles win fourth Unity cup in London
- Stakeholders call for more support in Nigeria’s theatre sector
- Nigerian army foils kidnap plot in Kogi
- NNPP ratifies new acting chairman
- Southwest Fulani Chiefs condemn kidnapping, dissociate selves from suspects
- Labour party names Gbwefi governorship candidate
- Ogazi disburses N12m to 600 women in Kokona
